Skip to main content
PLOS One logoLink to PLOS One
. 2022 Aug 8;17(8):e0271483. doi: 10.1371/journal.pone.0271483

Acute coronary syndrome versus acute myocarditis in young adults–value of speckle tracking echocardiography

Paulina Wieczorkiewicz 1,*, Karolina Supel 1, Katarzyna Przybylak 1, Michal Kacprzak 1, Marzenna Zielinska 1
Editor: Antonio Cannatà2
PMCID: PMC9359587  PMID: 35939417

Abstract

Purpose

Comparing myocarditis with an acute coronary syndrome (ACS)-like presentation and acute myocardial infarction (AMI) poses an important clinical challenge. The purpose of the study was to investigate the diagnostic value of the clinical, laboratory and especially echocardiographic characteristics including speckle tracking echocardiography (STE) of patients with ACS-like myocarditis and AMI.

Methods

We conducted a retrospective analysis comparing 69 symptomatic patients (≤ 45 years old), hospitalized at the Department of Interventional Cardiology (Medical University of Lodz, Poland) between April 2014 and June 2021 with an initial diagnosis of ST-segment elevation myocardial infarction.

Results

37 patients with the cardiac magnetic resonance–confirmed acute myocarditis and 32 patients diagnosed with AMI based on the clinical presentation, electrocardiogram and the presence of a culprit lesion on the coronary angiography were analysed including echocardiography parameters. On STE analysis an average global longitudinal (GLS), radial and circumferential strain including three—layers observation were significantly lower (absolute value) in patients with AMI versus acute myocarditis (p<0.05). There was no significant difference in Endo/Epi ratio (p = 0.144) between the groups. An average GLS < (-17.5) represented the optimal cut-off value for the myocarditis diagnosis.

Conclusion

In patients with AMI a significant reduction of global and three-layers strains compared to patients with myocarditis was detected. Furthermore, our analysis also confirmed the discriminative pattern of myocardial injury between the groups.

Introduction

Myocarditis is an inflammatory heart disease induced by both infectious and non-infectious causes [13]. It is estimated that the incidence of myocarditis fluctuates between 0.02 and 1.5% of the general population with the average age of patients from 20–51 years, mostly men [1, 4, 5]. Due to the heterogeneity of clinical presentation, which can range from asymptomatic to acute coronary syndrome (ACS) -like and acute heart failure, the diagnosis of acute myocarditis (AM) is still challenging [69]. When myocarditis is presented with chest pain, electrocardiographic changes with ST-segment deviation, raised cardiac troponin levels, differentiation from myocardial infarction (MI) is necessary [911]. Echocardiography findings including global ventricular dysfunction, regional wall motion abnormalities or diastolic dysfunction are also non-specific [6, 10]. Thus, a coronary angiography has been still performed in patients with inflammatory heart diseases in order to exclude obstructive coronary artery disease (CAD) [8, 10]. A final diagnosis of myocarditis is possible only on endomyocardial biopsy (EMB), which is still the diagnostic gold standard but due to its invasive character, low availability and small numbers of multidisciplinary teams with complementary competences in EMB procedure, extremely limited in clinical practice [6, 7, 10, 1214]. Hence, cardiac magnetic resonance imaging (CMR) has recently emerged as a reference standard for the diagnosis of acute myocarditis due to its ability to identify myocardial oedema and inflammation, as well as scarring associated with MI [1517]. It seems to be reasonable to first use CMR as a non-invasive tool for the tissue characterization of the myocardium in clinically stable patients presented with chest pain, ST segment elevation in electrocardiogram (ECG) and normal coronary arteries [6, 18]. However, CMR is expensive and not always available in many areas worldwide [6, 8, 10, 19]. One of the most commonly used devices in most centres is conventional transthoracic echocardiogram (TTE) but is often not sufficiently sensitive to detect subtle myocardial dysfunction [7, 8]. Therefore, other recently developed echocardiography-based methods such as speckle tracking echocardiography (STE) imaging emerged as an area of interest in the differential diagnosis of patients with ST-segment elevation [7, 10]. Two-dimensional STE allows clinicians more sophisticated assessment of left ventricular (LV) systolic and diastolic function including three-layers analysis [20].

The aim of this research is to investigate the diagnostic value of global longitudinal (GLS), radial (GRS) and circumferential strain (GCS) imaging by echocardiography as a differentiating tool in patients hospitalized with an initial diagnosis of ST-segment elevation myocardial infarction (STEMI). The following article was presented in accordance with the STROBE reporting checklist.

Methods

Study population

We retrospectively analysed 69 symptomatic patients (≤45 years old) urgently admitted to the Department of Interventional Cardiology (Medical University of Lodz, Poland) within 12h of onset symptoms between April 2014 and June 2021 with an initial diagnosis of STEMI. ST segment elevation was defined as a J point elevation in two contiguous leads with the cut-points: ≥0.25 mV in men below the age of 40 years, ≥0.2 mV in men over the age of 40 years, ≥0.15 mV in women in leads V2 –V3 and/or ≥0.1 mV in other leads. In order to confirm or exclude obstructive CAD, the invasive coronary angiography was performed in all cases. Patients were classified into two groups, according to their final diagnosis. Group 1: Patients diagnosed with MI based on the clinical presentation, ECG and the presence of a culprit lesion on the coronary angiography in accordance to European Society of Cardiology (ESC) Guidelines on Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation (2017). All patients have undergone successful angioplasty of infarct-related artery. Group 2: Patients with normal coronary angiogram diagnosed with acute myocarditis due to the clinical presentation and typical findings in CMR. EMB was performed in no cases. Diagnosis of acute myocarditis was confirmed according to the updated 2018 Lake Louise criteria in whole population [7, 21]. Only 7 symptomatic patients fulfilling the criteria of age and ST-segment elevation in ECG on admission but finally diagnosed as aortic dissection, toxin abuse, takotsubo syndrome, pericarditis or myocardial infarction type 2 were excluded from the study. In case of patients with toxin abuse or takotsubo syndrome, the CMR was also performed. In addition, patients aged <18 years and patients with poor TTE image quality were not included.

All the data were collected from patients’ clinical notes and electronic records and independently assessed by two investigators.

Clinical data including typical symptoms, history of recent infection, cardiovascular risk factors—arterial hypertension, family history of CAD, smoking, diabetes mellitus, obesity defined as a body mass index (BMI) ≥30kg/m2 were reviewed. With the reference to the laboratory findings, beside C-reactive protein (CRP) and white blood cells count (WBC), we assessed the high-sensitive cardiac troponin T (TnT) and CK-MB mass level as a biomarker for the myocardial damage. The TnT cut-off point was 14 ng/l.

The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Local Ethics Committee (No RNN/03/20/KE). All data were fully anonymized. The informed consent was not required.

Echocardiography

TTE was performed on the third day of hospitalization using a high-definition Vivid E9 Ultrasound System with a 3.5-Mhz transducer (GE Healthcare, Horten, Norway) in accordance with the European Association of Cardiovascular Imaging (EACVI) recommendations. Images were optimized for gain, compression, depth and sector width and acquired at frame rates of 70–90 frames/s. Three levels (basal, middle and apical) of LV short axis and three LV apical views (4-,3- and 2-chamber) were acquired in the left lateral decubitus position during a breath hold. LV diameters were measured in long-axis parasternal standard views. LV ejection fraction (EF) and left atrial (LA) volume were assessed by means of biplane modified Simpson’s rule from the apical 4- and 2-chamber views, as appropriate. LA volume was indexed to body surface area (BSA). Tricuspid annular plane systolic excursion (TAPSE) in M-mode measurement, transmitral blood flow pattern and tricuspid regurgitant velocity by means of pulsed and continuous Doppler wave respectively were also obtained. Tissue doppler imaging was used to calculate E/E’ ratio and assess the diastolic function. Datasets were digitally stored for offline analysis (EchoPAC, Horten, Norway, version 201 software).

Speckle tracking echocardiography

Echocardiographic strain imaging is a new non-invasive method for assessment of myocardial function. A 2D speckle tracking analysis was retrospectively performed using a commercially available software package (EchoPAC, Horten, Norway, version 201 software) by the two experienced and independent observers. The myocardial borders were manually traced during end systole in three apical views and in three levels of the short axis views to analyse longitudinal (myocardial shortening in the long-axis plane), radial (myocardial thickening in a short-axis plane) and circumferential (myocardial shortening in a short-axis plane) strain. The ROI (region of interest) was defined by the endocardial border. Images were automatically divided into six standard segments in each view and the time-strain curves were generated. If the software program deemed a segment “unacceptable”, a manual adjustment was performed. Peak systolic strain was determined as the maximum value of the strain during systole. Global longitudinal, radial and circumferential strain were defined as the average strain at end systole in 18 segments. A specific option of the software for three-layers analysis was used to calculate endocardial, mid-wall and epicardial GCS with relative curves. The ratio of endocardial GCS to epicardial GCS (Endo/Epi ratio) was figured for the assessment of the strain gradient [20, 2224]. Normal ranges of reference values for layer-specific strain were based on Nagata et al. [20].

Cardiac magnetic resonance imaging

In patients with normal coronary arteries, the CMR was done as soon as the clinical situation allowed during the same hospitalisation using the 1.5-Tesla MRI scanner (Siemens Magnetom Avanto) with phased-array body coil, ECG monitoring and enhancing contrast Gadovist, Bayer Schering Pharma, Berlin, Germany and dedicated syngo.via MR Cardiac Analysis software. Diagnosis of acute myocarditis was confirmed according to the updated 2018 Lake Louise criteria on the whole population [1, 7, 21, 25]. According to the protocols recommended by the Society for the Cardiovascular Magnetic Resonance, regional or global myocardial oedema and non-ischaemic myocardial injury were identified as areas of high-signal intensity T2-weighted imaging and the regional late gadolinium enhancement (LGE) signal increase, respectively [26].

Statistical analysis

All the statistical analyses were performed using the Statistica Software ver. 13.1 (StatSoft Inc., Tulsa, OK, USA). The classified variables were expressed as numbers and percentages, while the continuous variables were expressed as mean ± standard deviation. The continuous values were analysed with the Mann-Whitney U test whereas the Chi-square test was used for the discrete values. A receiver-operator characteristic (ROC) curve investigation was constructed to select optimal cut-off values of strain measurements. In addition, the analysis was expanded to Spearman’s rank correlation coefficient. A p values <0.05 was considered statistically significant.

Results

69 symptomatic patients ≤45 years old including 13 females (18.8%) and 56 males (81.2%) were enrolled in this study. The mean age was 28 ± 8 and 40 ± 4 for CMR-confirmed acute myocarditis and MI respectively (p = 0.000). Demographic, clinical characteristics and laboratory parameters are presented in Table 1.

Table 1. Baseline characteristics.

Myocarditis Myocardial infarction P value
N = 37 N = 32
Age [years] 28 ± 8 40 ± 4 0.000
Sex (male) 33 (89.2%) 23 (71.9%) 0.012
Smoking 16 (43.2%) 23 (71.8%) 0.017
Hypertension 5 (13.5%) 15 (46.9%) 0.005
Diabetes 2 (5.4%) 2 (6.25%) 0.713
Obesity BMI≥30 [kg/m2] 3 (8.1%) 10 (31.2%) 0.032
Family history od CAD 11 (29.7%) 11 (34.4%) 0.680
Symptoms
    Chest pain 36 (97.3%) 30 (93.8%) 0.898
    Dyspnea 3 (8.1%) 9 (28.1%) 0.062
Recent infection * 29 (78.4%) 0 0.000
Parameters on admission
    HR (heart rate) [bpm] 82 ± 13 83 ± 14 0.707
    Syst. blood pressure [mmHg] 126 ± 12 150 ± 24 0.000
    Diast. blood pressure 76 ± 10 91 ± 22 0.000
Laboratory findings
    WBC [x109 /l] ** 10.4 ± 3.6 12.9 ± 6.4 0.108
    RBC [x1012 /l] ** 4.9 ± 0.4 5.0 ± 0.5 0.543
    TnT [ng/l] ** 643 ± 626 641 ± 598 0.021
    TnT (after 24h) 932 ± 778 2958 ± 2742 0.000
    CKMB [ng/ml] ** 31.6 ± 32.8 29.8 ± 48.0 0.307
    CKMB (after 24h) 43.2 ± 50.2 140.3 ± 167.0 0.005
    CRP [mg/l] (max) 71.7 ± 67.4 38.8 ± 54.5 0.006

All values presented as mean ± SD or N (%).

* <3 weeks before admission.

** on admission.

Nearly all patients had chest pain. 78.5% of patients with myocarditis reported the history of recent infection (p = 0.000). No significant differences between the groups were revealed concerning diabetes mellitus, family history of CAD, symptoms and heart rate on admission. The main cardiovascular risk factors: smoking, hypertension and obesity (defined as BMI ≥30kg/m2) were more frequent in patients finally diagnosed as MI (p<0.05). Patients with the CMR-confirmed myocarditis had significantly lower value of systolic and diastolic blood pressure measured on admission with p = 0.000 for both.

The TnT level on admission as well as after 24 hours were abnormal in groups but revealed different release patterns. Amid patients diagnosed with myocarditis there was observed higher TnT level on admission with a relatively low peak in 24-hour observation. In contrast, mean TnT level on admission for MI was lower with a higher peak after 24 hours with p<0.05.

In MI group the most numerous were patients with anterolateral myocardial infarction (N = 10). 7 patients presented MI of anteroseptal wall. 3 patients were diagnosed as MI of inferior, inferobasal wall and right ventricle (RV). 5 patients had isolated inferior wall infarct, 2 patients presented inferolateral MI, 4 inferior and inferobasal. Only 1 patient was diagnosed as MI of inferior wall and RV.

As far as echocardiographic features are concerned LVEF was lower in patients with myocardial infarction rather than acute myocarditis (mean 50% ± 8 vs 56% ± 7, p = 0.002). The median of impaired segments in MI and myocarditis group was 4 (IQR 3–6.5) and 1 (IQR 0–4) respectively. Diastolic posterior wall and intraventricular septum thickness were significantly higher in myocardial infarction group with p<0.05 for both. Further diastolic dysfunction measured by E/E’ average was more deteriorated in patients with infarction compared to acute myocarditis (mean 8 ± 2 vs 7 ± 2, p = 0.000). There were no significant differences in left atrium volume index (LAVi), LV diastolic diameters and right ventricular function measured by TAPSE between the groups. A complete description of echocardiographic parameters is reported in Table 2.

Table 2. Baseline echocardiographic parameters.

Myocarditis Myocardial infarction P value
N = 37 N = 32
PWd [mm] 10 ± 1 11± 2 0.002
IVSd [mm] 10 ± 1 12 ± 2 0.000
LVEDD [mm] 50 ± 4 50 ± 5 0.538
LVESD [mm] 34 ± 6 34 ± 6 0.976
LAVi [ml/m2] 30 ± 5 30 ± 12 0.708
TAPSE [mm] 23 ± 3 22 ± 4 0.182
LV EF [%] 56 ± 7 50 ± 8 0.002
E/A ratio 1.5 ± 0.3 1.2 ± 0.3 0.000
E/E’ average 7 ± 2 8 ± 2 0.000

All values presented as mean ± SD.

On speckle tracking analysis, an average GLS, GRS as well as GCS including three—layers observation were significantly lower (absolute value) in patients with acute myocardial infarction (AMI) versus acute myocarditis with p<0.05. There was no significant difference in Endo/Epi ratio (mean 2.3 ± 0.7 vs 2.5 ± 0.6, p = 0.144). Distribution of Endo/Epi ratio values having regard to normal reference according to Nagata at al. is presented in Fig 1. Complete STE parameters are reported in Table 3.

Fig 1. Layer–specific circumferential strain (Endo/Epi ratio) in the myocarditis and MI groups.

Fig 1

Data are shown as Tukey boxplot and raw data, taking into account normal references values for age, p = 0.144.

Table 3. STE data.

Myocarditis Myocardial infarction P value
N = 37 N = 32
Global longitudinal strain [%]
Apical four chamber -18.0 ± 2.9 -15.0 ± 4.1 0.001
Apical two chamber -19.2 ± 3.4 -15.9 ± 4.2 0.002
Apical three chamber -18.8 ± 2.9 -14.2 ± 7.3 0.000
Average -18.7 ± 2.7 -15.4 ± 3.9 0.000
Global radial strain [%]
Average 33.4 ± 12.0 23.3 ± 11.5 0.001
Global circumferential strain [%]
Epicardial -10.4 ± 3.1 -8.8 ± 3.3 0.036
Mid-wall -17.3 ± 3.2 -13.8 ± 4.6 0.005
Endocardial -25.3 ± 6.3 -21.0 ± 7.2 0.009
Endo/Epi ratio 2.5 ± 0.6 2.3 ± 0.7 0.144
Average -17.5 ± 4.3 -14.7 ± 4.8 0.036

All values presented as mean ± SD.

An average LV GLS < (-17.5) represented the optimal cut-off value for the acute myocarditis diagnosis with the area under the ROC curve (AUC) 0.737 [95% CI 0.617–0.857] (Fig 2A). Despite preserved ejection fraction in both groups GLS was significantly lower (absolute value) in patients diagnosed as acute myocardial infarction compared to the myocarditis group. GLS in patients with myocarditis is located in the majority within normal reference values of strain correctly to age (Fig 2B). In addition, by bivariate correlation analysis, there was a strong parallel between GLS average value and LVEF in whole population (Fig 3A) and in both groups separately (Fig 3B and 3C). The examples of the two different longitudinal strain bull’s eye plots in patients admitted with an initial diagnosis of STEMI and with the final diagnosis of myocardial infarction and acute myocarditis are presented in Fig 4A and 4B respectively. In contrast to patients with myocarditis it confirms the ischaemic pattern of myocardial injury related strictly to heart vascularization in patients diagnosed as AMI.

Fig 2.

Fig 2

(a) ROC curve of the GLS average [%] for the diagnosis of clinically suspected myocarditis. The AUC was 0.737 (standard error = 0.061, 95% confidence interval 0.795–0.954). It shows that the sensitivity and specificity of the GLS is adequate in statistics (b) Global longitudinal strain [%] in the myocarditis and MI groups including normal reference of strain. Data are shown as Tukey boxplot, (p = 0.000).

Fig 3.

Fig 3

Scatter plot of a strong correlation between GLS average [%] and left ventricular ejection fraction [%] in whole population (a), myocarditis group (b) and myocardial infarction group (c).

Fig 4.

Fig 4

Example of the longitudinal strain bull’s eye plot derived from two-dimensional speckle tracking imaging in patients admitted with an initial diagnosis of anterolateral STEMI and with the final diagnosis of myocardial infarction resulted from occlusion of the left anterior descending artery (a) and acute myocarditis (b).

The average GCS and layer–specific GCS among the groups presented as Tukey boxplots (mean ± SD) are provided in Figs 5 and 6, respectively. We also compared the results to the normal reference values of strain.

Fig 5. Global circumferential strain (average) [%] concerning normal reference values.

Fig 5

Tukey boxplot (mean ± SD).

Fig 6. Global circumferential endocardial and epicardial strain in the myocarditis and MI groups.

Fig 6

Data are shown as Tukey boxplots, taking into account normal reference values for age, p<0.05 (a) Endocardial GCS [%]. (b) Epicardial GCS [%].

Our analysis revealed the statistically significant differences between the groups in all three layers and average (p<0.05). It also confirmed the discriminative pattern of myocardial injury with three—layers damage in patients with ischaemic myocardial infarction and midwall to epicardial distribution excluding endocardial location in patients diagnosed as acute myocarditis.

Discussion

Our study suggests that a combination of clinical and laboratory findings in conjunction with echocardiography parameters with particular reference to STE of LV might become a valuable tool for confirming the diagnosis of acute myocarditis in patients with chest pain, presenting ST-segment elevation on admission and normal coronary arteries in coronary angiography. Nowadays, EMB is the only method enabling a certain diagnosis of myocarditis, however infrequently followed in clinical practice [1, 6, 7, 12]. Cardiac magnetic resonance is currently the preferred non-invasive tool for myocardial tissue characterization providing the essential information about morphology and function of cardiac structures, myocardial oedema, hyperemia and myocardial scarring in LGE [1, 7]. In myocardial scar the wash out of gadolinium contradistinctively to normal myocardium is deferred. Different patterns of LGE indicate the ischaemic or non-ischaemic cause of myocardial injury. Ischaemic necrosis expands from the endocardium to epicardium revealed the transmural character of changes, whereas in non-ischaemic necrosis LGE is limited to midwall and epicardial layers [17, 18, 2729]. Although basic TTE, including LVEF assessment, is the most often used tool to evaluate LV function, it is often not sufficient enough to detect subtle myocardial dysfunction [30]. Novel echocardiographic techniques such as STE constitute a great advantage to provide a sensitive quick diagnostic examination in the acute phase of disease [7, 12]. In our study, we found the corresponding to CMR LGE images layer–specific strain impairment including transmural distribution in patients diagnosed as acute coronary syndrome and non–transmural, subepicardial involvement in patients with acute myocarditis. In the latter we observed the values of endocardial GCS within the normal ranges for age in contrast to patients with confirmed obstructive CAD, p = 0.009. The presence of mainly epicardial strain impairment in combination with preserved endocardial strain value can be supportive to exclude ischemic heart disease in case of acute coronary syndrome–like presentation of myocarditis especially when CMR is not easily available [6, 27]. Moreover, according to the references, it seems that global longitudinal myocardial function is reduced when extensive transmural myocardial damage is observed [18]. In our research, we confirmed the statistically significant difference (p = 0.000) in GLS values between the myocarditis and MI group with higher values (absolute values) in patients diagnosed as AM and the cut-off point for suspected myocarditis defined as the GLS < (-17.5) (AUC 0.737, 95% CI 0.795–0.954). On the other hand, there was no significant difference as far as Endo/Epi ratio is concerned. It might be associated with the observed immediate improvement of endocardial strain in patients with acute STEMI undergoing primary percutaneous coronary intervention (PCI) [31]. Myocardial injury due to ischemic heart disease spreads from the endocardium towards epicardium [27]. According to Atıcı et al. in patients with the phenomenon of no-reflow after PCI multilayer strain imaging revealed lower strain values particularly in endocardial layer [32]. Non-invasive diagnostics including speckle tracking echocardiography may constitute a new starting point for consideration about separation the myocarditis group without additional imaging in patients with an initial diagnosis of STEMI on admission at which the obstructive CAD had been excluded.

Study limitations

Some limitations of this study need to be noted. Initially, this is a single-center, retrospective study resulting in the relatively small number of patients. Secondly, despite the fact that, according to the position of experts group in ESC guidelines, EMB is still regarded as a gold standard for the diagnosis of myocarditis, it was not performed in any case. In our study, the diagnosis of acute myocarditis was confirmed in compliance with the updated 2018 Lake Louise criteria in the whole population (increased signal intensity in T2-weighted imaging and increased signal intensity with a non-ischeamic distribution pattern in LGE images).

There are few studies providing the information about the normal ranges of the left ventricular strain in adults [19, 33, 34]. For further optimization multi-center studies are required.

Conclusion

In patients with AMI a significant reduction of global and three-layers strains compared to patients with myocarditis was detected. Furthermore, corresponding to CMR LGE images layer–specific strain impairment might provide valuable information to complement the diagnosis of acute myocarditis especially when CMR is not easily available in patients without coronary artery disease.

Supporting information

S1 Table. Minimal data set.

(PDF)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Tyminska A, Ozieranski K, Caforio ALP, et al. Myocarditis and inflammatory cardiomyopathy in 2021. an update. Polish Archive of Internal Medicine 2021;131(6). doi: 10.20452/pamw.16010 [DOI] [PubMed] [Google Scholar]
  • 2.Wang Z, Wang Y, Lin H, et al. Early characteristic of fulminant myocarditis vs non-fulminant myocarditis. Medicine 2019;98:8e14697. doi: 10.1097/MD.0000000000014697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fung G, Luo Honglin, Qiu Y, et al. Myocarditis. Circulation Research. 2016;118:496–514. doi: 10.1161/CIRCRESAHA.115.306573 [DOI] [PubMed] [Google Scholar]
  • 4.Gottlieb M, Bridwell R, Petrak V, Long B. Diagnosis and management of myocarditis: an evidence-based review for the emergency medicine clinician. The Journal of Emergency Medicine 2021; doi: 10.1016/j.jemermed.2021.03.029 [DOI] [PubMed] [Google Scholar]
  • 5.Mosebach CM, Tandon V, Kumar M. Acute myocarditis presenting as acute coronary syndrome. Cureus 2019;11(7):e5212. doi: 10.7759/cureus.5212 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sperlogano S, D’Amato A, Tagliamonte E, et al. Acute myocarditis: prognostic role of speckle tracking echocardiography and comparison with cardiac magnetic resonance features. Heart and Vessels 2021; 10.1007/s00380-021-01893-0. [DOI] [PubMed] [Google Scholar]
  • 7.Meindl C, Paulus M, Poschenrieder F, Zeman F, Maier LS, Debl K. Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolinium enhancement by CMR. Clinical Research in Cardiology 2021; doi: 10.1007/s00392-021-01885-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Saricam E, Saglam Y, Harizolan T. Clinical evaluation of myocardial involvement in acute myopericarditis in young adults. BMC Cardiovascular Disorders 2017;17:129. doi: 10.1186/s12872-017-0564-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pellation C, Monney P, Ludman AJ, et al. Clinical features of myocardial infarction and myocarditis in young adults: a retrospective study. BMJ Open 2012;2:e001571. doi: 10.1136/bmjopen-2012-001571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Leitman M, Vered Z, Tyomkin V, et al. Speckle tracking imaging in inflammatory heart diseases. International Journal of Cardiovascular Imaging 2018;34:787–792. doi: 10.1007/s10554-017-1284-y [DOI] [PubMed] [Google Scholar]
  • 11.Constantini M, Tritto C, Licci E, et al. Myocarditis with ST-elevation Myocardial Infarction presentation in young man. A case series of 11 patients. International Journal of Cardiology 2005;101:157–158. doi: 10.1016/j.ijcard.2004.01.023 [DOI] [PubMed] [Google Scholar]
  • 12.Degiovanni A, Pastore MC, Spinoni EG, Focardi M, Cameli M, Patii G. Usefulness of a multiparametric evaluation including global longitudinal strain for an early diagnosis of acute myocarditis. International Journal of Cardiovascular Imaging 2021; doi: 10.1007/s10554-021-02299-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Heidecker B, Ruedi G, Baltensperger N, et al. Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study. Swiss Medical Weekly 2019;149:w20098. doi: 10.4414/smw.2019.20098 [DOI] [PubMed] [Google Scholar]
  • 14.Seferovic PM, Tsutsui H, McNamara DM, et al. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. Journal of Cardiac Failure 2021;vol. 27, No.7. [DOI] [PubMed] [Google Scholar]
  • 15.Chopra H, Arangalage D, Bouleti C, et al. Prognostic value of the infarct–and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. International Journal of Cardiology 2016; 212:63–69. doi: 10.1016/j.ijcard.2016.03.004 [DOI] [PubMed] [Google Scholar]
  • 16.Stensaeth KH, Fossum E, Hoffmann P, et al. Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. International Journal of Cardiovascular Imaging 2011;27:355–365. doi: 10.1007/s10554-010-9671-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Vermes E, Carbone I, Friedrich MG, Merchant N. Patterns od myocardial late enhancement: Typical and atypical features. Archives of Cardiovascular Disease 2012;105:300–3008. [DOI] [PubMed] [Google Scholar]
  • 18.Tunnemann-Tarr A, Stobe S, Laufs U, Hagendorff A, Tayal B. Speckle tracking echocardiography in a patients with viral myocarditis and acute myocardial infarction. Journal of Cardiology Cases 2020;22:184–191. doi: 10.1016/j.jccase.2020.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hausvater A, Pasupathy S, Tornvall P, et al. ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries. International Journal of Cardiology 2019;287:128–131. doi: 10.1016/j.ijcard.2019.04.028 [DOI] [PubMed] [Google Scholar]
  • 20.Nagata Y, Chien-Chia Wu V, Otsuji Y, Takeuchi M. Normal range of myocardial layer-specific strain using two-dimensional speckle tracking echocardiography. PLoS ONE 12(6):e0180584. doi: 10.1371/journal.pone.0180584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018. Dec 18;72(24):3158–3176. doi: 10.1016/j.jacc.2018.09.072 [DOI] [PubMed] [Google Scholar]
  • 22.Voigt JU, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for @D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. European Heart Journal–Cardiovascular Imaging 2015;16:1–11. doi: 10.1093/ehjci/jeu184 [DOI] [PubMed] [Google Scholar]
  • 23.Kurt M, Tanboga IH, Aksakal E. Two-dimensional strain imaging: Basic prnciples and technical consideration. The Eurasian Journal of Medicine 2014;46:126–30. doi: 10.5152/eajm.2014.28 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dandel M, Lehmkuhl H, Knosalla C, Suramelashvili N, Hetzer R. Strain and strain rate imaging by echocardiography–basic concepts and clinical applicability. Current Cardiology Reviews 2009;5:133–148. doi: 10.2174/157340309788166642 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ederhy S, Salem JE, Dercle L, et al. Role of cardiac imaging in the diagnosis od immune checkpoints inhibitors related myocarditis. Frontiers in Oncology 2021; doi: 10.3389/fonc.2021.640985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kramer C.M.; Barkhausen J.; Bucciarelli-Ducci C.; Flamm S.D.; Kim R.J.; Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J. Cardiovasc. Magn. Reson. 2020, 22, 17. doi: 10.1186/s12968-020-00607-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kim S, Cho DH, Kim MN, et al. Transmural difference in myocardial damage assessed by layer-specific strain analysis in patients with ST elevation myocardial infarction. Scientific Reports 2020;10:11104. doi: 10.1038/s41598-020-68043-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Huang H, Liu XQ, Huang BT, Yao HM, Zhang XL. Layer-specific Analysis in Patients with ST Segment Elevation Myocardial Infarction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016. Sep;47(5):743–748. Chinese. . [PubMed] [Google Scholar]
  • 29.Becker M, Ocklenburg C, Altiok E, et al. Impact of infarct transmurality on layer–specific impairment of myocardial function: a myocardial deformation imaging study. European Heart Journal 2009;30:1467–1476. doi: 10.1093/eurheartj/ehp112 [DOI] [PubMed] [Google Scholar]
  • 30.Faganello G, Collia D, Furlotti S, et al. A new integrated approach to cardiac mechanics: reference values for normal left ventricle. International Journal of Cardiovascular Imaging 2020; 36:2173–2185. doi: 10.1007/s10554-020-01934-1 [DOI] [PubMed] [Google Scholar]
  • 31.Sun JP, Liang Y, Zhang F, et al. Serial assessment of focal myocardial function after percutaneous coronary intervention for ST–elevation myocardial infarction: value of layer–specific speckle tracking echocardiography. Echocardiography 2020. Sep;37(9):1413–1421. doi: 10.1111/echo.14772 [DOI] [PubMed] [Google Scholar]
  • 32.Atıcı A, Barman HA, Erturk E, et al. Multilayer longitudinal strain can help predict the development of no-reflow in patients with acute coronary syndrome without ST elevation. International Journal Cardiovascular Imaging. 2019. Oct;35(10):1811–1821. doi: 10.1007/s10554-019-01623-8 [DOI] [PubMed] [Google Scholar]
  • 33.Toshimitsu T, Postolache A, Dulgheru R, et al. Echocardiographic reference ranges for normal left ventricular layer–specific strain: results from the EACVI NORRE study. European Heart Journal—Cardiovascular Imaging 2020; 21:896–905. doi: 10.1093/ehjci/jeaa050 [DOI] [PubMed] [Google Scholar]
  • 34.Truong T, Hoang T, Khanh NP, et al. Normal ranges of left ventricular strain by three–dimensional speckle tracking echocardiography in adults: a systematic review and meta–analysis. Journal of the American Society of Echocardiography 2019. Dec;32(12):1586–1597.e5. doi: 10.1016/j.echo.2019.07.012 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Antonio Cannatà

1 May 2022

PONE-D-22-08288ACUTE CORONARY SYNDROME VERSUS ACUTE MYOCARDITIS IN YOUNG ADULTS – VALUE OF SPECKLE TRACKING ECHOCARDIOGRAPHYPLOS ONE

Dear Dr. Wieczorkiewicz,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, the statistics should be implemented before consideration of further revisions. 

Please submit your revised manuscript by Jun 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Antonio Cannatà

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

Additional Editor Comments:

In addition to reviewers' comments, the authors should provide statistical correction for potential confounders especially when validating the role of GLS. Although may suffer collinearity, the variable might be tested against LVEF to highlight its predictive role.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this small retrospective study, authors aim at investigating the value of speckle tracking echocardiography in the differential diagnosis between acute coronary syndrome and acute myocarditis. Due to the possible clinical overlap between these two conditions the differential diagnosis is challenging, sometimes impossible in the acute phase, therefore coronary angiography is still largely performed in the emergency setting to exclude SCA. For this reason, the topic of the paper is very actual, however there are several points pf the work which should be addressed.

Major comments:

- From my point of view, the main limitation of the paper is the lack of clinical implications of the study. Authors conclude that patients with AMI have a significant reduction of global and three layers strains as compared to those with myocarditis. However, it seems difficult to consider using echocardiography strain analysis to discriminate between patients who should undergo coronary angiography and those who should not in the setting of acute chest pain and ST segment elevation ant EKG.

- In the paragraph “conclusion” authors state that “specific strain impairment might provide valuable information to complement the diagnosis of acute myocarditis when CMR is not easily available”. I would rather say that “specific strain impairment might provide valuable information to complement the diagnosis of acute myocarditis when CMR is not easily available in patients without coronary artery disease”.

- Due to the retrospective nature of the study a multivariate analysis should be performs in order to correct the results for confounders especially considering that patients with myocardial infarction were older, had higher Tn levels and more cardiovascular risk factors.

Minor comments:

- Page 3 authors say: “EMB is still the diagnostic gold standard but extremely limited in the clinical practice. Please consider citing the recently published Position Statement by Seferovic et al (DOI: 10.1016/j.cardfail.2021.04.010);

- Please check minor English typos.

Reviewer #2: In the present paper the authors investigate the diagnostic value of clinical and instrumental tools, focusing in particular on speckle tracking echocardiography, in patients with acute coronary syndrome-like myocarditis and acute myocardial infarction. They found that patients with AMI have a significant reduction of global strains and a different layer involvement compared to patients with myocarditis. Thus, they suggest that speckle tracking analysis may become a valuable tool to differentiate these two entities.

The topic is very actual and interesting, however some issues should be addressed:

- As the authors have mentioned, the paper presents some limitations like the small sample size or the absence of a histological confirmation of the myocarditis diagnosis. Furthermore, for patients with AMI diagnosis some information is lacking like the STEMI localization and if there is a different a bigger strain impairment in patients with a more estensive infarction. Also, it is not specify if all AMI patients have undergone PCI.

- There are conflicting data about the differences in layer-specific strain impairment. The major finding of the present study is that the presence of a mainly epicardial strain impairment with preserved endocardial strain can suggest a diagnosis of myocarditis and exclude ACS, in which the three layers are involved. Conversely, the value of endocardial strain, which should be the most compromised, has the higher value (-21) and there was not a significant difference in endo/epi ratio between the two groups.

- The fact that the absolute GLS value was significantly lower in patients diagnosed as AMI compared to the myocarditis group does not provide a relevant additional information given that also the LVEF is lower in the AMI group.

- It is curious that PWd and IVSd were significantly higher in myocardial infarction group because, despite the higher prevalence of hypertension in this group, in the myocarditis group it is expected a ventricular pseudohypertrophy due to myocardial edema.

- It could be interesting to complete the speckle tracking analysis with also the right ventricolare values (in particular for inferior STEMI).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Aug 8;17(8):e0271483. doi: 10.1371/journal.pone.0271483.r002

Author response to Decision Letter 0


31 May 2022

Dear Sir/Madam,

I would like to submit the revised version of the manuscript entitled “Acute coronary syndrome versus acute myocarditis in young adults – value of speckle tracking echocardiography” by Wieczorkiewicz P, Supel K, Przybylak K, Kacprzak M, Zielinska M to be considered for publication as an original article in the PLOS ONE.

On behalf of all co-authors, I would like to thank you very much for all the reviewers’ comments and suggestions.

Appreciating their input and effort, we have revised the manuscript in accordance with all the recommendations.

The first and foremost we have supplemented the statistics with the scatter plots of a strong correlation between GLS average and left ventricular ejection fraction in whole population and in both groups separately, what confirms the predictive role of GLS in whole analysis. The similar pattern of the correlations proves that this relation does not differentiate the groups.

Other changes are described in the Response to the Reviewers.

We believe that these corrections will improve the manuscript in terms of its educational value.

We are looking forward to hearing from you at your earliest convenience.

Best regards,

Paulina Wieczorkiewicz

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Antonio Cannatà

5 Jul 2022

ACUTE CORONARY SYNDROME VERSUS ACUTE MYOCARDITIS IN YOUNG ADULTS - VALUE OF SPECKLE TRACKING ECHOCARDIOGRAPHY

PONE-D-22-08288R1

Dear Dr. Wieczorkiewicz,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antonio Cannatà

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: no additive comment

the manuscript is OK

the results and the discussions are OK

the figure are OK as well as the references

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Acceptance letter

Antonio Cannatà

29 Jul 2022

PONE-D-22-08288R1

Acute Coronary Syndrome versus Acute Myocarditis in young adults – value of Speckle Tracking Echocardiography

Dear Dr. Wieczorkiewicz:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Antonio Cannatà

Academic Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES